Enzi Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$891K Sell
3,510
-45
-1% -$10.5K 0.28% 32
2026
Q1
$869K Buy
3,555
+14
+0.4% +$3.26K 0.3% 29
2025
Q4
$774K Buy
3,541
+14
+0.4% +$2.77K 0.27% 32
2025
Q3
$678K Buy
3,527
+44
+1% +$7.54K 0.24% 33
2025
Q2
$546K Sell
3,483
-2
-0.1% -$307 0.2% 37
2025
Q1
$540K Buy
3,485
+420
+14% +$65.7K 0.22% 33
2024
Q4
$445K Sell
3,065
-136
-4% -$21.1K 0.17% 42
2024
Q3
$517K Buy
3,201
+111
+4% +$17.7K 0.2% 36
2024
Q2
$453K Buy
3,090
+83
+3% +$12.3K 0.2% 37
2024
Q1
$444K Hold
3,007
0.21% 34
2023
Q4
$471K Buy
+3,007
New +$461K 0.23% 33

Other funds holding JNJ

Enzi Wealth's JNJ Position: Q2 2026 in Review

Enzi Wealth reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, selling an estimated $10.5K and leaving 3,510 shares worth $891K. The position accounts for 0.28% of the portfolio, ranked #32.

Enzi Wealth first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,167 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Enzi Wealth held 3,510 shares of Johnson & Johnson worth $891K as of Q2 2026.
  • Enzi Wealth sold 45 Johnson & Johnson shares in Q2 2026, an estimated $10.5K.
  • Johnson & Johnson made up 0.28% of Enzi Wealth's portfolio in Q2 2026, its #32 holding.
  • Enzi Wealth first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,167 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Enzi Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.